What is the Frontier Health and Medical Research Program?
The Frontier Health and Medical Research initiative is a 2-stage program that will provide a total of $570 million over 9 years. It will support researchers to explore bold ideas that could have a global impact.
The Frontier Health and Medical Research Initiative enables researcher collaborations to explore bold and innovative ideas and/or make discoveries of great potential and global impact, through research relevant to any area of health and medical service delivery.
Grants will enable or facilitate ground-breaking research with the potential to transform health, across any area of activities within the health system.
Australia has the potential to lead health service delivery and create new markets for health related products by applying cutting-edge science and technologies to innovation that has the potential to improve human health.
The Frontier Health and Medical Research initiative will encourage Australia’s best and brightest researchers to create talented and ambitious multi-disciplinary teams. These teams will work together to achieve practical translation through research of big bold ideas that will significantly improve health care.
The objectives of the Frontier Health and Medical Research initiative are to:
- identify and support ground-breaking and innovative research projects that have the potential to extend existing knowledge and transform health care in Australia and globally
- stimulate the creation of novel research programs and industries
- deliver new health care methods that will impact on an area, or areas, of the health care continuum (prevention to clinical management)
- accelerate new technological advances in health care
- promote multi-disciplinary partnerships and approaches that enable transformative research and innovation.
The MRFF Frontier Health and Medical Research Program Stage Two – provides multi-disciplinary teams with up to $100 million to implement their novel and transformative research projects.
Stage Two projects will enable selected research plans developed under Stage One to receive investment to develop their ideas. These ideas will revolutionise healthcare with new technological advances or approaches. Stage Two grants will vary depending on applicant requirements, but they would typically be in the range of $10 to $20 million per annum for 5 years.
To be eligible for the Frontier Health and Medical Research initiative your project must:
- be aimed at the objectives
- have at least $250,000 in eligible expenditure
- include one or more of the following eligible activities:
- development/installation of research equipment
- employment of personnel and/or
- other direct research costs.
To be eligible for the Frontier Health and Medical Research initiative you must:
- have an Australian Business Number (ABN)
- be incorporated in Australia
and in accordance with s20 and s24 of the MRFF Act 20152, be one of the following entities:
- a medical research institute
- a university
- a corporate Commonwealth entity
- a corporation (including businesses and not for profits)
- a state or territory government
- a state or territory government entity.
Joint applications are encouraged, provided you have a lead organisation who is the main driver of the project and is eligible to apply.
Applications open 1 July 2020 and close 14 July 2020.
How to get the stage 2 funding?
Who are the competitors?
- harnessing next-generation brain imaging technology to diagnose and treat epilepsy ($1 million)
- developing a new interface between the brain and a machine, to help people regain eyesight, movement or other nerve functions ($0.9 million)
- developing a national database of antibiotic resistance, to allow resistant strains to be traced, isolated and treated ($1 million)
- investigating large-scale use of an Australian method for controlling the spread of Zika virus, dengue fever and other mosquito-borne diseases ($1 million)
- developing new technologies to improve women’s sexual and reproductive health ($0.9 million)
- using 4D diagnostic technology to accurately assess lung function in people of all ages, including the very young and old ($1 million)
- using the latest genome editing technology to rapidly detect and identify infectious disease and antimicrobial resistance ($1 million)
- using therapeutic ultrasound to treat brain disorders, including dementia ($1 million)
- testing a new technology that stimulates the spinal cord to treat cerebral palsy ($0.7 million)
- developing new technologies to care for people who have had a stroke before they reach hospital ($1 million)
How to win stage 2 funding?
How the Government score your stage 2 application?
- Assessment criterion 1: Project Impact (34% weighting).
- Assessment criterion 2: Project methodology (33% weighting).
- Assessment criterion 3: Capacity, capability and resources to deliver the project (33% weighting).
- Assessment criterion 4: Overall Value and Risk of the Project (non-weighted).
Everyone is good at research….
- cutting edge ideas and research technology
- capacity and capability for translational research
- team’s track record undertaking translationally focussed research
- a sound project plan including your governance structure
Where should you be spending your time?
- Who are the commercialisation partners? – that the project will be entering the commercialisation stage and will not be dependent on further Commonwealth funding by the end of Stage Two
- What is the annual cost of the problem? – a defined health and medical research problem
- How does it get to market? – credible pathway to impact after five years of funding
We dont care about the research!
- Frontier Health and Medical Research initiative – Stage 2 Application
- Frontier Health and Medical Research initiative – Stage 2 Guidelines
- Frontier Health and Medical Research initiative – Stage 2 Detailed tips (Bulletpoint)
- Frontier Health and Medical Research initiative – Stage 2 Sample Agreement
- Frontier Health and Medical Research initiative – Stage 2 Mandatory Attachments
- Frontier Health and Medical Research Initiative – Stage 1 Guidelines
Round 1 Recipients
The program awarded the following stage 1 grants under the Frontier Health and Medical Research initiative, as at 30 September 2019.
|Funded Institution||Project Name||Chief Investigator||Total Funding|
|Australian Lung Health Initiative Pty Ltd||4D Functional diagnosis: a new frontier in lung health for children||Prof Andreas Fouras||$960,000|
|Burnet Institute||EVE-M (Enhancing the Vaginal Environment and Microbiome) Initiative||Prof Gilda Tachedjian||$895,346|
|Florey Institute of Neuro-science and Mental Health||Precision Medicine in Epilepsy||Prof Graeme Jackson||$999,956|
|Monash University||An Innovative Public Health Program Against Mosquito-Borne Diseases||Prof Scott O’Neill||$964,700|
|Monash University||Cortical Frontiers: Commercialising Brain Machine Interfaces||Prof Arthur Lowery||$924,100|
|Saluda Medical Pty Limited||Cerebral palsy treatment by closed loop electrical stimulation||Prof John Parker||$747,596|
|The University of Queensland||Therapeutic Ultrasound for the Treatment of Brain Disorders||Prof Juergen Goetz||$1,000,000|
|University of Melbourne||Using disruptive technologies to transform prehospital care for stroke||Prof Geoffrey Donnan||$1,000,000|
|University of Technology Sydney||Disruptive technologies to trace, track & tackle antibiotic resistance||Prof Steven Djordjevic||$998,731|
|Walter and Eliza Hall Institute of Medical Research||c-FIND: CRISPR Frontier Infection Diagnostics to Detect Infection||Prof Marc Pellegrini||$1,000,000|